MyD88 Protein

MyD88 Protein

Pathway Diagram

```mermaid
flowchart TD
MYD88["MYD88<br/>Myeloid Differentiation<br/>Primary Response Protein"]
TLR4["TLR4<br/>Toll-like Receptor 4"]
INNATE["Innate Immunity<br/>Pathway"]
INFLAM["Inflammation<br/>Response"]
NEUROINFLAM["Neuroinflammation"]
ALS["Amyotrophic Lateral<br/>Sclerosis (ALS)"]
PD["Parkinson's Disease"]
MS["Multiple Sclerosis<br/>(MS)"]
ISCHEMIA["Cerebral Ischemia"]
NEUROPROT["Neuroprotective<br/>Effects"]
THERAPEUTIC["Therapeutic<br/>Target"]
AGING["Age-related<br/>Neurodegeneration"]
IMMUNE_REG["Immune System<br/>Regulation"]
MICROGLIA["Microglial<br/>Activation"]
CYTOKINES["Pro-inflammatory<br/>Cytokines"]

MYD88 -->|"activates"| TLR4
MYD88 -->|"regulates"| INNATE
MYD88 -->|"dual role"| INFLAM
TLR4 -->|"triggers"| MICROGLIA
MICROGLIA -->|"produces"| CYTOKINES
CYTOKINES -->|"leads to"| NEUROINFLAM

MYD88 -->|"contributes to"| ALS
MYD88 -->|"activates"| PD
MYD88 -->|"modulates"| MS
MYD88 -->|"protects against"| ISCHEMIA

NEUROINFLAM -->|"promotes"| ALS
NEUROINFLAM -->|"exacerbates"| PD
NEUROINFLAM -->|"drives"| MS

MYD88 -->|"enables"| NEUROPROT
NEUROPROT -->|"counteracts"| NEUROINFLAM

MYD88 -->|"represents"| THERAPEUTIC
THERAPEUTIC -->|"targets"| AGING
IMMUNE_REG -->|"modulated by"| MYD88

MyD88 Protein

Pathway Diagram

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">MyD88 Protein</th>
</tr>
<tr> [@okun2011]
<td class="label">Gene</td>
<td>[MYD88](/genes/myd88)</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/Q99836" target="_blank">Q99836</a></td>
</tr>
<tr>
<td class="label">PDB</td>
<td>2Z5V, 3MOP, 4DOM</td>
</tr>
<tr>
<td class="label">Mol. Weight</td>
<td>33 kDa</td>
</tr>
<tr>
<td class="label">Localization</td>
<td>Cytoplasm</td>
</tr>
<tr>
<td class="label">Family</td>
<td>MyD88 adaptor-like (Mal) family</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/als)</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/als" style="color:#ef9a9a">ALS</a>, <a href="/wiki/aging" style="color:#ef9a9a">Aging</a>, <a href="/wiki/als" style="color:#ef9a9a">Als</a>, <a href="/wiki/alzheimer" style="color:#ef9a9a">Alzheimer</a>, <a href="/wiki/asthma" style="color:#ef9a9a">Asthma</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">469 edges</a></td>
</tr>
</table>

MyD88 Protein

Introduction

Myd88 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

MyD88 (Myeloid Differentiation Primary Response 88) is encoded by the [MYD88](/genes/myd88) gene. It belongs to the MyD88 adaptor-like (Mal) family and has a molecular weight of approximately 33 kDa^[@akira2004]. This protein is localized to Cytoplasm and plays a significant role in the pathogenesis of [Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease), [ALS](/diseases/als).

Overview

MyD88 (Myeloid differentiation primary response 88) is a critical adaptor protein in Toll-like receptor (TLR) and IL-1R signaling pathways. MyD88 contains an N-terminal death domain that interacts with TLRs and IL-1R, and a C-terminal Toll/IL-1 receptor domain. Upon receptor activation, MyD88 recruits IRAK kinases, leading to downstream NF-κB and MAPK activation. MyD88 is essential for innate immune responses in the brain, where it mediates microglial activation by TLR ligands and pro-inflammatory cytokines. In neurodegenerative diseases, MyD88-dependent signaling contributes to chronic neuroinflammation. MyD88 deficiency in [microglia](/cell-types/microglia-neuroinflammation) reduces amyloid-β plaque burden and improves cognitive function in mouse models of Alzheimer's disease. MyD88 also plays roles in Parkinson's disease ([α-synuclein](/proteins/alpha-synuclein)-induced inflammation) and ALS. Targeting MyD88 signaling represents a therapeutic strategy for reducing harmful neuroinflammation.

Structure

The MyD88 protein has been characterized structurally through X-ray crystallography. Available PDB structures include: 2Z5V, 3MOP, 4DOM^[@lin2010].

The protein's three-dimensional structure can also be explored via the [AlphaFold Protein Structure Database](https://alphafold.ebi.ac.uk/entry/Q99836).

Normal Function

Under physiological conditions, MyD88 performs essential functions in innate immunity. It is primarily found in Cytoplasm and contributes to normal cellular homeostasis, signaling, and immune function.

TLR/IL-1R Signaling Adaptor

MyD88 is the central adaptor protein for most Toll-like receptors and IL-1 receptor family members:

• [TLR4](/entities/tlr4) signaling — Mediates LPS-induced inflammation
• IL-1R signaling — Essential for IL-1β and IL-18 signaling
• TLR2/TLR6 — Bacterial lipoprotein recognition
• TLR7/TLR8 — Viral single-stranded RNA sensing

Signaling Cascade

Upon receptor activation:

Role in Disease

MyD88 is implicated in the following neurodegenerative conditions:

• [Alzheimer's Disease](/diseases/alzheimers-disease) — Activated by [Aβ](/proteins/amyloid-beta) oligomers; mediates chronic neuroinflammation; contributes to pro-inflammatory cytokine production
• [Parkinson's Disease](/diseases/parkinsons-disease) — Involved in microglial activation; mediates α-synuclein-induced inflammation; contributes to dopaminergic neuron loss
• [ALS](/diseases/als) — Elevated in ALS patient [microglia](/entities/microglia); contributes to inflammatory motor neuron injury

Therapeutic Targeting

MyD88 represents an important therapeutic target. Multiple drug development programs are exploring strategies to modulate its function:

• Small molecule inhibitors: Under development for inflammatory diseases
• Microglial modulation: Reduce neuroinflammation via MyD88 inhibition
• Combination approaches: MyD88 targeting with other neuroprotective strategies

External Links

• UniProt: [https://www.uniprot.org/uniprot/Q99836](https://www.uniprot.org/uniprot/Q99836)
• AlphaFold: [MyD88 Protein](https://alphafold.ebi.ac.uk/entry/Q99836)
• PDB: [2Z5V](https://www.rcsb.org/structure/2Z5V), [3MOP](https://www.rcsb.org/structure/3MOP), [4DOM](https://www.rcsb.org/structure/4DOM)

See Also

• [Proteins Index](/proteins)
• [Genes Index](/genes)
• [Diseases Index](/diseases)
• [Mechanisms Index](/mechanisms)
• [TLR Signaling](/mechanisms/tlr-signaling)
• [Neuroinflammation](/mechanisms/neuroinflammation)

Brain Atlas Resources

• Allen Human Brain Atlas: [MyD88 expression search](https://human.brain-map.org/microarray/search/show?search_term=MYD88)
• Allen Mouse Brain Atlas: [MyD88 search](https://mouse.brain-map.org/search/index.html?query=MYD88)
• Allen Cell Type Atlas: [Transcriptomic cell type reference](https://portal.brain-map.org/atlases-and-data/rnaseq)

Background

The study of Myd88 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

Related Hypotheses

From the [SciDEX Exchange](/exchange) — scored by multi-agent debate

• [Selective TLR4 Modulation to Prevent Gut-Derived Neuroinflammatory Priming](/hypothesis/h-f3fb3b91) — <span style="color:#81c784;font-weight:600">0.67</span> · Target: TLR4